Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The CRISPR Gene Editing Market?

In recent years, there’s been a significant expansion in the size of the crispr gene editing market. This market is anticipated to swell from its value of $2.26 billion in 2024 to hit $2.88 billion by 2025, indicating a compound annual growth rate (CAGR) of 27.1%. Factors contributing to this historical growth include a surge in demand for genome editing technologies, greater government funding, an increase in cancer diagnoses, a rise in chronic diseases, heightened awareness of CRISPR technology, and an expansion in the healthcare infrastructure.

Predictions suggest that the market size for crispr gene editing will experience a significant surge in the coming years. Projected growth estimates it could reach $6.99 billion by 2029, growing at a compound annual growth rate (CAGR) of 24.9%. Factors contributing to this future growth are several, including rising instances of genetic disorders, an increasing focus on precision medicine, escalating investments in CRISPR-focused research and development, a growing elderly population, and an enhanced emphasis on gene therapy procedures. Trend projections for this period indicate advancements in gene editing technology, an increase in the volume of research studies, progress in drug discovery and development, innovations in delivery methods, and the uptake of CRISPR-modified agriculture.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15549&type=smp

What Are The Primary Factors Supporting The CRISPR Gene Editing Market Expansion?

The surge in genetic disorders is set to fuel the expansion of the CRISPR gene editing market. Genetic disorders, which are health issues caused by irregularities in the genome, including mutations in single or multiple genes or chromosomal abnormalities, are on the rise due to genetic mutations, older populations, and consanguineous marriages. CRISPR gene editing plays a crucial role in combating genetic disorders by offering exact and targeted alterations to the DNA. Additionally, scientists utilize CRISPR to detect and rectify specific mutations causing genetic disorders, recover normal functionality and ease disease symptoms, apparent in ailments like cystic fibrosis and sickle cell anemia. For instance, the Cystic Fibrosis (CF) Foundation, a non-profit organization based in the US, reported a rise in the number of people suffering from cystic fibrosis in July 2022. In 2022, almost 40,000 children and adults in the United States and over 105,000 individuals globally have been diagnosed with cystic fibrosis. Hence, the escalating prevalence of genetic disorders is spearheading the development of the CRISPR gene editing market.

Which Segments Define The Structure Of The CRISPR Gene Editing Market?

The crispr gene editingmarket covered in this report is segmented –

1) By Type: CRISPR-Associated Nuclease (Cas Nuclease); Guide Ribonucleic Acid (RNA); Deoxyribonucleic Acid (DNA) Ligase; Restriction Endonuclease; Other Types

2) By Services: Design Tools; Plasmid And Vector; CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA); Delivery System Products; Other Services

3) By Technology: CRISPR Or Cas9; Zinc Finger Nucleases; Other Technologies

4) By Application: Agricultural; Biomedical; Industrial; Genome Engineering; Disease Models; Functional Genomics; Other Applications

5) By End User: Academic Institutes And Research Centers; Biotechnology Companies; Contract Research Organizations (CROs); Pharmaceutical And Biopharmaceutical Companies

Subsegments:

1) By CRISPR-Associated Nuclease (Cas Nuclease): Cas9; Cas12; Cas13; Other Cas Nucleases

2) By Guide Ribonucleic Acid (RNA): Single-guide RNA (sgRNA); Dual-guide RNA; Synthetic Guide RNA

3) By Deoxyribonucleic Acid (DNA) Ligase: T4 DNA Ligase; E. coli DNA Ligase; Other DNA Ligases

4) By Restriction Endonuclease: Type II Restriction Enzymes; Type I And III Restriction Enzymes; Other Restriction Enzymes

5) By Other Types: CRISPR Delivery Systems; CRISPR Plasmids; CRISPR-Based Diagnostic Tools

Which Disruptive Trends Are Driving Change Across The CRISPR Gene Editing Market?

Leading firms in the CRISPR gene editing market are concentrating their efforts on the creation of novel products like gene therapy, which can cater to a wider customer base, drive sales, and boost revenue. Gene therapy is a medical process that employs genes to cure, prevent, or treat various diseases and disorders. For instance, the US-based federal agency, the US Food and Drug Administration (FDA), gave its approval for Casgevy, a cell-based gene therapy, in December 2023, to treat sickle cell disease. Casgevy therapy employs CRISPR/Cas9, a kind of genome editing technology, to modify Hematopoietic stem cells.

Who Are The Primary Market Leaders In The CRISPR Gene Editing Market?

Major companies operating in the CRISPR gene editing market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., GenScript, Integrated DNA Technologies Inc., Takara Bio Inc., OriGene Technologies Inc., Intellia Therapeutics Inc., New England Biolabs, Synthego, Arbor Biotechnologies Inc., Rockland Immunochemicals Inc., Cellectis, Editas Medicine, Caribou Biosciences Inc., System Biosciences LLC, Applied StemCell, Addgene, Mirus Bio LLC, Excision BioTherapeutics Inc., GeneCopoeia Inc., ToolGen Inc., Cellecta Inc., CRISPR Therapeutics, ERS Genomics Limited

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

What Regional Factors Are Accelerating Growth In The CRISPR Gene Editing Market?

North America was the largest region in the CRISPR gene editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15549&type=smp

Browse Through More Reports Similar to the Global CRISPR Gene Editing Market 2025, By The Business Research Company

Crispr And Cas Gene Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

Crispr Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/crispr-technology-global-market-report

Gene Editing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model